Related Experiment Video
Updated: Sep 10, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Levodropropizine: Comprehensive Review of the Peripheral Antitussive
Sandeep Nayar1, Agam Vora2, Mangesh Tiwaskar3
1Principal Director and Head of Department, Department of Respiratory Medicine, Allergy & Sleep Disorders, BLK-Max Super Speciality Hospital, New Delhi, India.
Levodropropizine, a peripheral cough suppressant, offers effective symptom relief for nonproductive cough. It provides comparable efficacy to central antitussives but with a superior safety profile and fewer side effects.
Area of Science:
- Pharmacology
- Clinical Medicine
- Respiratory Medicine
Background:
- Cough is a prevalent symptom in Indian primary care, significantly impacting patients' quality of life.
- Symptomatic relief of cough is often necessary alongside etiological treatment.
- Nonproductive cough management benefits from antitussive agents.
Purpose of the Study:
- To review the pharmacological aspects of levodropropizine.
- To summarize clinical evidence supporting levodropropizine's efficacy and safety.
- To define levodropropizine's therapeutic role in managing cough.
Main Methods:
- Comprehensive literature review of drug aspects.
- Analysis of clinical trial data on efficacy and safety.
- Evaluation of levodropropizine's use across various age groups and etiologies.
Main Results:
- Levodropropizine demonstrates comparable efficacy to central antitussives in reducing cough severity and frequency.
- Levodropropizine exhibits a superior safety profile with minimal central nervous system (CNS) side effects.
- Extensive studies support its use in diverse patient populations and conditions.
Conclusions:
- Levodropropizine is a valuable nonopioid, peripheral antitussive for symptomatic cough management.
- Its favorable safety profile makes it a prudent choice compared to traditional central antitussives.
- This review consolidates evidence for levodropropizine's established place in cough therapy.
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:

